Annexon Inc

ANNXNASDAQ · USD
4.23USD0.00 (+1.44%)
1210

Annexon Inc (ANNX) Straddle

ANNX straddle scan found 18 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 68.0%.

Read more

Trading a ANNX straddle lets you take a pure volatility position on Annexon Inc without committing to a direction. Annexon Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate ANNX straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on ANNX profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Annexon Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the ANNX straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated neurodegeneration. Its product candidates include ANX005, a monoclonal antibody, which is in Phase II/III clinical trials to treat patients with guillain- barré syndrome; Phase II trial in patients with warm autoimmune hemolytic anemia; and Phase II clinical trial for Huntington's disease and amyotrophic lateral sclerosis.

The company is also developing ANX009 that is in Phase Ib trial in patients with lupus nephritis; and ANX007, which is in Phase II clinical trials to treat patients with geographic atrophy. In addition, it develops ANX105, an investigational monoclonal antibody targeting neurodegenerative indications; and ANX1502, an investigational oral small molecule for the treatment of certain autoimmune indications. The company was incorporated in 2011 and is headquartered in Brisbane, California.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the ANNX straddle is the cleanest expression of that view. Our scanner prices every ANNX straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a ANNX straddle into a catalyst or short a ANNX straddle to harvest decay, the options straddle setups that matter are all in one place.

Dec 18, 202610.00$5.609157%68.0%$15.60$4.4022
Dec 18, 202612.00$8.809157%50.5%$20.80$3.2013
Apr 16, 20279.00$7.1321057%48.1%$16.13$1.880
Jan 15, 202711.00$8.3011957%47.4%$19.30$2.702
Dec 18, 20268.00$5.209157%45.9%$13.20$2.800
Dec 18, 20267.00$4.409157%43.7%$11.40$2.6030
Apr 16, 20277.00$5.5821057%41.3%$12.58$1.430
Jan 15, 20278.00$5.7811957%40.9%$13.78$2.236
Dec 18, 20266.00$3.839157%37.3%$9.83$2.1860
Jan 15, 20276.00$4.2511957%34.8%$10.25$1.75246

As of September 18, 2026

Find the right straddle before volatility moves

Track ANNX straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.

Start your 14-day free trial